# Post-Marketing Surveillance of TISSUCOL for Hemostasis in Subjects Undergoing Vascular Reconstruction With Polytetrafluoroethylene (PTFE) Prosthesis

> **NCT00163592** · — · COMPLETED · sponsor: **Baxter Healthcare Corporation** · enrollment: 60 (—)

## Conditions studied

- Femoral Vascular Anastomosis

## Interventions

- **DRUG:** Tissucol®
- **PROCEDURE:** Control: Conventional treatment, i.e. compression with swabs

## Key facts

- **NCT ID:** NCT00163592
- **Lead sponsor:** Baxter Healthcare Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2003-09
- **Primary completion:** —
- **Final completion:** 2004-02
- **Target enrollment:** 60 (—)
- **Last updated:** 2006-10-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00163592

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00163592, "Post-Marketing Surveillance of TISSUCOL for Hemostasis in Subjects Undergoing Vascular Reconstruction With Polytetrafluoroethylene (PTFE) Prosthesis". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00163592. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*